Insulin aspart, recombinant Subcutaneous and Lotemax Eye Gel
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lotemax Eye Gel and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Lotemax (ophthalmic), Lotemax
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lotemax Eye Ointment
- Insulin aspart, recombinant Subcutaneous-Lotemax ophthalmic
- Insulin aspart, recombinant Subcutaneous-Lotemax SM
- Insulin aspart, recombinant Subcutaneous-Lotemax SM ophthalmic
- Insulin aspart, recombinant Subcutaneous-Lotensin
- Insulin aspart, recombinant Subcutaneous-Lotensin HCT
- Lotemax Eye Gel-Insulin degludec
- Lotemax Eye Gel-Insulin Degludec (U-100) Prefilled Pens
- Lotemax Eye Gel-Insulin Degludec (U-100) Vials
- Lotemax Eye Gel-Insulin Degludec (U-200) Prefilled Pens
- Lotemax Eye Gel-Insulin degludec and liraglutide
- Lotemax Eye Gel-Insulin degludec and liraglutide Subcutaneous